The McKesson You're Actually Joining — Fortune 9, Specialty-First Healthcare Backbone

A grounding tour of what McKesson actually does at its $300B+ scale, why it sits at the center of the U.S. healthcare supply chain, and how CEO Brian Tyler is reshaping the company around oncology, biopharma services, and prescription technology. By the end, you'll be able to explain the company's business model, segments, and recent strategic pivot in a way that signals you've done real homework.